Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 37
Phase 43

Trial Status

Completed10
Recruiting2
Terminated4
Other2

Role Distribution

Principal Investigator16
Other Roles2
PI Rate89%

Activity Timeline

Clinical Trials (18)

NCT07575269Not ApplicableRecruiting
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
Paroxysmal Atrial Fibrillation (PAF)Persistent Atrial Fibrillation
PrincipalinvestigatorStart date: 2026-07-07
NCT06699056Recruiting
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Atrial EnlargementCardiotoxicityConduction Defect+12 more
PrincipalinvestigatorStart date: 2024-11-21
NCT04830774Not ApplicableUnknown
Natural History of COVID-19-Related Atrial Fibrillation
Atrial Fibrillation New OnsetCOVID-19
PrincipalinvestigatorStart date: 2021-04-15
NCT03193021Not ApplicableCompleted
AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID
Surgical Wound
PrincipalinvestigatorStart date: 2017-09-20
NCT02481102Completed
EASYER (EpiAccess SYstem Registry) A Post Market Observational Registry
Arrhythmias, Cardiac
PrincipalinvestigatorStart date: 2015-06-30
NCT01959425Phase 4Terminated
Oral Anticoagulation Therapy Pilot Study
Paroxysmal Atrial Fibrillation
PrincipalinvestigatorStart date: 2013-04-17

Showing 10 of 18 trials

Research Network

Collaboration Network

66 collaborators·112 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sameer Jamal, MD

Hackensack Meridian Health

Very Similar
2 trials

Shared therapeutic areas:

Arrhythmias, CardiacAtrial EnlargementAtrial Fibrillation+14 more

Worked with same sponsors:

Peerbridge Health, Inc
Collaborated on 1 trial
Similarity Score174%

Sandeep Gulati, PhD

Peerbridge Health, Inc

Very Similar
3 trials

Shared therapeutic areas:

SyncopeAtrial EnlargementConduction Defect+14 more

Worked with same sponsors:

Peerbridge Health, Inc
Collaborated on 1 trial
Similarity Score174%

Johanna P Contreras, MD

MOUNT SINAI HOSPITAL

Very Similar
1 trials

Shared therapeutic areas:

Atrial EnlargementCardiotoxicityConduction Defect+12 more

Worked with same sponsors:

Peerbridge Health, Inc
Collaborated on 1 trial
Similarity Score154%

Sachin Parikh, MD

Henry Ford Hospital

Very Similar
1 trials

Shared therapeutic areas:

Atrial EnlargementCardiotoxicityConduction Defect+12 more

Worked with same sponsors:

Peerbridge Health, Inc
Collaborated on 1 trial
Similarity Score154%

Brian Kolski, MD

Orange County Heart Institute

Very Similar
1 trials

Shared therapeutic areas:

Atrial EnlargementCardiotoxicityConduction Defect+12 more

Worked with same sponsors:

Peerbridge Health, Inc
Collaborated on 1 trial
Similarity Score154%

Frank Mazzola, MD

South Heart Clinic

Very Similar
1 trials

Shared therapeutic areas:

Atrial EnlargementCardiotoxicityConduction Defect+12 more

Worked with same sponsors:

Peerbridge Health, Inc
Collaborated on 1 trial
Similarity Score154%

Vivek Reddy, MD

Icahn School of Medicine at Mount Sinai

Similar
28 trials

Shared therapeutic areas:

Atrial FibrillationTachycardia, VentricularPersistent Atrial Fibrillation+2 more

Worked with same sponsors:

Abbott Medical DevicesBiosense Webster, Inc.+1 more
Collaborated on 1 trial
Similarity Score54%

Francis Marchlinski, MD

University of Pennsylvania

Moderately Similar
4 trials

Shared therapeutic areas:

Atrial FibrillationIschemicMonomorphic Ventricular Tachycardia+1 more

Worked with same sponsors:

Abbott Medical DevicesBiosense Webster, Inc.+1 more
Collaborated on 2 trials
Similarity Score48%

David Wilber, MD

Loyola University

Moderately Similar
2 trials

Shared therapeutic areas:

Arrhythmias, CardiacAtrial FibrillationIschemic+1 more

Worked with same sponsors:

Biosense Webster, Inc.
Collaborated on 1 trial
Similarity Score44%

Luigi Di Biase, Md, PhD

Texas Cardiac Arrhythmia Research Foundation

Moderately Similar
3 trials

Shared therapeutic areas:

Atrial FibrillationHeart FailureMigraine Disorders

Worked with same sponsors:

Casa Sollievo della Sofferenza IRCCSCatholic University, Italy+7 more
Collaborated on 2 trials
Similarity Score38%

Publications (0)

No publications found for this investigator.

Clinical Trials (18)

Showing 18 of 18 trials

NCT07575269Not ApplicablePrincipalInvestigator

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

Paroxysmal Atrial Fibrillation (PAF)Persistent Atrial Fibrillation
Recruiting
NCT06699056PrincipalInvestigator

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Atrial EnlargementCardiotoxicityConduction Defect+12 more
Recruiting
NCT04830774Not ApplicablePrincipalInvestigator

Natural History of COVID-19-Related Atrial Fibrillation

Atrial Fibrillation New OnsetCOVID-19
Unknown
NCT04037397Phase 3PrincipalInvestigator

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)

Atrial Fibrillation
Completed
NCT03683030Phase 3PrincipalInvestigator

Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation

Atrial Fibrillation
Completed
NCT03193021Not ApplicablePrincipalInvestigator

AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID

Surgical Wound
Completed
NCT02481102PrincipalInvestigator

EASYER (EpiAccess SYstem Registry) A Post Market Observational Registry

Arrhythmias, Cardiac
Completed
NCT01959425Phase 4PrincipalInvestigator

Oral Anticoagulation Therapy Pilot Study

Paroxysmal Atrial Fibrillation
Terminated
NCT01557842Phase 4StudyChair

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators

IschemicVentricular Tachycardia
Terminated
NCT00729911Phase 4PrincipalInvestigator

Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD

Heart Failure
Completed
NCT01362738Phase 3PrincipalInvestigator

Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation

Persistent Atrial Fibrillation
Completed
NCT01391091Phase 3PrincipalInvestigator

Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine

Atrial FibrillationMigraine
Completed
NCT01439386Phase 3PrincipalInvestigator

Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter

Atrial ArrhythmiaQuality of Life
Completed
NCT01456000Phase 3PrincipalInvestigator

HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

Paroxysmal Atrial Fibrillation
Completed
NCT02130765Not ApplicablePrincipalInvestigator

Substrate Targeted Ablation Using the FlexAbilityâ„¢ Ablation Catheter System for the Reduction of Ventricular Tachycardia

Monomorphic Ventricular Tachycardia
Terminated
NCT02219841PrincipalInvestigator

Impact of Life-Style Modification On Ablation Outcome in Atrial Fibrillation

Atrial FibrillationObesity
Unknown
NCT02533843Phase 3StudyDirector

Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation

Atrial Fibrillation
Completed
NCT02637947Not ApplicablePrincipalInvestigator

Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population

Tachycardia, Ventricular
Terminated

All 18 trials loaded